Skip to main content
. 2025 Aug 19;9(8):e25.00192. doi: 10.5435/JAAOSGlobal-D-25-00192

Table 2.

Univariable and Multivariable Analyses of 90-Day Complications for Instrumented and Noninstrumented Matched Cohorts (Controlled for Age, Sex, and Elixhauser Comorbidity Index)

Factor or Variable Univariate Analysis Multivariate Analysis
Instrumented Fusion (n = 19,374) NonInstrumented Fusion (n = 4850) P Valuea Odds Ratio (95% CI) P Valuea
Any adverse events 2127 (11.0%) 579 (11.9%) 0.061 1.10 (1.00-1.21) 0.056
Severe adverse events 938 (4.8%) 278 (5.7%) 0.012 1.20 (1.04-1.38) 0.010
 Cardiac arrest 11 (0.1%) <10 (0.2%) 1 1.09 (0.30-3.92) 0.892
 Myocardial infarction 122 (0.6%) 28 (0.6%) 0.754 0.92 (0.61-1.39) 0.686
 Pulmonary embolism 159 (0.8%) 39 (0.8%) 0.980 0.98 (0.69-1.40) 0.920
 Sepsis 196 (1.0%) 58 (1.2%) 0.295 1.19 (0.88 - 1.59) 0.254
 Deep vein thrombosis 271 (1.4%) 73 (1.5%) 0.623 1.08 (0.83-1.40) 0.563
 Surgical site infection 372 (1.9%) 136 (2.8%) <0.001 1.48 (1.21-1.80) <0.001
Minor adverse events 1601 (8.3%) 418 (8.6%) 0.441 1.05 (0.94-1.17) 0.423
 Pneumonia 264 (1.4%) 70 (1.4%) 0.717 1.06 (0.82-1.39) 0.653
 Urinary tract infection 846 (4.4%) 213 (4.4%) 0.970 1.00 (0.86-1.17) 0.963
 Acute kidney injury 366 (1.9%) 105 (2.2%) 0.236 1.14 (0.92-1.42) 0.240
 Wound dehiscence 229 (1.2%) 67 (1.4%) 0.290 1.17 (0.89-1.54) 0.251
 Hematoma 120 (0.6%) 26 (0.5%) 0.571 0.87 (0.57-1.33) 0.510
 Transfusion 99 (0.5%) 34 (0.7%) 0.135 1.38 (0.93-2.04) 0.108

CI = confidence interval

a

Bonferroni correction was used to account for multiple comparisons. The adjusted significance threshold is P ≤ 0.003, and bolded values indicate statistical significance at this level.

Multivariable odds ratio computed with instrumented group as reference group.